PFG Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $385K | Sell |
15,983
-2,407
| -13% | -$63K | 0.02% | 597 |
|
|
2026
Q1 | $516K | Buy |
18,390
+1,199
| +7% | +$31.9K | 0.03% | 536 |
|
|
2025
Q4 | $428K | Sell |
17,191
-4,695
| -21% | -$118K | 0.02% | 561 |
|
|
2025
Q3 | $558K | Buy |
21,886
+2,339
| +12% | +$57.7K | 0.02% | 539 |
|
|
2025
Q2 | $474K | Sell |
19,547
-481
| -2% | -$11.2K | 0.02% | 440 |
|
|
2025
Q1 | $507K | Sell |
20,028
-1,743
| -8% | -$45.6K | 0.03% | 462 |
|
|
2024
Q4 | $578K | Sell |
21,771
-682
| -3% | -$18.5K | 0.04% | 432 |
|
|
2024
Q3 | $650K | Buy |
22,453
+481
| +2% | +$14K | 0.04% | 387 |
|
|
2024
Q2 | $615K | Sell |
21,972
-2,404
| -10% | -$66.2K | 0.04% | 388 |
|
|
2024
Q1 | $676K | Sell |
24,376
-1,573
| -6% | -$43.6K | 0.05% | 338 |
|
|
2023
Q4 | $747K | Sell |
25,949
-3,146
| -11% | -$95.1K | 0.06% | 311 |
|
|
2023
Q3 | $965K | Sell |
29,095
-16,349
| -36% | -$578K | 0.09% | 261 |
|
|
2023
Q2 | $1.67M | Sell |
45,444
-1,456
| -3% | -$56.7K | 0.13% | 194 |
|
|
2023
Q1 | $1.91M | Sell |
46,900
-4,876
| -9% | -$211K | 0.16% | 158 |
|
|
2022
Q4 | $2.65M | Buy |
51,776
+4,921
| +11% | +$236K | 0.26% | 101 |
|
|
2022
Q3 | $2.05M | Sell |
46,855
-387
| -0.8% | -$18.8K | 0.23% | 123 |
|
|
2022
Q2 | $2.48M | Buy |
47,242
+2,102
| +5% | +$107K | 0.28% | 84 |
|
|
2022
Q1 | $2.34M | Sell |
45,140
-235
| -0.5% | -$12.2K | 0.23% | 95 |
|
|
2021
Q4 | $2.68M | Buy |
45,375
+4,579
| +11% | +$227K | 0.26% | 105 |
|
|
2021
Q3 | $1.75M | Sell |
40,796
-1,937
| -5% | -$85.8K | 0.19% | 159 |
|
|
2021
Q2 | $1.67M | Buy |
42,733
+2,050
| +5% | +$79.7K | 0.19% | 155 |
|
|
2021
Q1 | $1.47M | Buy |
40,683
+14,023
| +53% | +$498K | 0.19% | 159 |
|
|
2020
Q4 | $981K | Buy |
26,660
+2,686
| +11% | +$98.5K | 0.17% | 160 |
|
|
2020
Q3 | $829K | Buy |
23,974
+499
| +2% | +$17.5K | 0.16% | 169 |
|
|
2020
Q2 | $754K | Sell |
23,475
-2,172
| -8% | -$73.8K | 0.17% | 157 |
|
|
2020
Q1 | $878K | Buy |
25,647
+2,267
| +10% | +$77.2K | 0.24% | 119 |
|
|
2019
Q4 | $866K | Buy |
23,380
+476
| +2% | +$17K | 0.21% | 135 |
|
|
2019
Q3 | $776K | Sell |
22,904
-34
| -0.1% | -$1.24K | 0.21% | 137 |
|
|
2019
Q2 | $937K | Buy |
22,938
+2,851
| +14% | +$113K | 0.25% | 122 |
|
|
2019
Q1 | $774K | Buy |
20,087
+12,322
| +159% | +$493K | 0.24% | 134 |
|
|
2018
Q4 | $308K | Buy |
7,765
+776
| +11% | +$32.2K | 0.1% | 221 |
|
|
2018
Q3 | $292K | Sell |
6,989
-174
| -2% | -$6.7K | 0.23% | 115 |
|
|
2018
Q2 | $247K | Buy |
7,163
+316
| +5% | +$10.8K | 0.22% | 122 |
|
|
2018
Q1 | $231K | Buy |
+6,847
| New | +$235K | 0.22% | 129 |
|
Other funds holding PFE
AIM
SLAM
CWP
PFG Advisors's PFE Position: Q2 2026 in Review
PFG Advisors reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $63K and leaving 15,983 shares worth $385K. The position accounts for 0.02% of the portfolio, ranked #597.
PFG Advisors first reported a position in PFE in Q1 2018 and has held it in 34 quarters since. The position peaked at $2.68M in Q4 2021. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- PFG Advisors held 15,983 shares of Pfizer worth $385K as of Q2 2026.
- PFG Advisors sold 2,407 Pfizer shares in Q2 2026, an estimated $63K.
- Pfizer made up 0.02% of PFG Advisors's portfolio in Q2 2026, its #597 holding.
- PFG Advisors first reported a position in Pfizer in Q1 2018 and has held it in 34 quarters since.
- PFG Advisors's Pfizer position peaked at $2.68M in Q4 2021.
- 1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.